tilisolol has been researched along with arotinolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, S; Nagatomo, T; Nakagawa, Y; Nakahara, H; Sasaki, M; Tsuchihashi, H | 1 |
| Kinoshita, M; Liu, Q; Nakae, I; Takahashi, M; Takaoka, A | 1 |
2 other study(ies) available for tilisolol and arotinolol
| Article | Year |
|---|---|
Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
Topics: Adrenergic beta-Antagonists; Animals; Dihydroalprenolol; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoquinolines; Membranes; Myocardial Contraction; Myocardium; Neuraminidase; Propanolamines; Radioligand Assay; Rats; Trachea | 1984 |
Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Vessels; Dogs; Drug Interactions; Female; Glyburide; Hemodynamics; Isoquinolines; Male; Potassium Channels; Propanolamines; Propranolol; Vascular Resistance; Vasodilation; Vasodilator Agents | 1996 |